Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Central nervous system leukemia

S M Blaney¹, D G Poplack

¹Department of Pediatrics, Baylor College of Medicine, Houston, TX 77024, USA.

Current Opinion in Oncology

|January 1, 1996

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates.

Cancer chemotherapy and pharmacology·2010

Same author

Differential expression of survivin splice isoforms in medulloblastomas.

Neuropathology and applied neurobiology·2007

Same author

A phase I study of irinotecan administered on a weekly schedule in pediatric patients.

Pediatric blood & cancer·2005

Same author

Phase I trial of intrathecal liposomal cytarabine in children with neoplastic meningitis.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2004

Same author

Pediatric phase I trial and pharmacokinetic study of the platelet-derived growth factor (PDGF) receptor pathway inhibitor SU101.

Cancer chemotherapy and pharmacology·2004

Same author

The development of camptothecin analogs in childhood cancers.

The oncologist·2001

Same journal

Artificial intelligence-augmented robotic surgery in gynecologic oncology: intraoperative assistance and analytics.

Current opinion in oncology·2026

Same journal

Artificial intelligence in cervical cancer screening and triage: a role-stratified systematic review and bivariate meta-analysis.

Current opinion in oncology·2026

Same journal

Deep learning assisting the surgical management of gynecologic cancers.

Current opinion in oncology·2026

Same journal

Pain management in pancreatic cancer: time to change our strategy!

Current opinion in oncology·2026

Same journal

Systemic radionuclide treatments in gastro-entero-pancreatic neuroendocrine tumours.

Current opinion in oncology·2026

Same journal

Lifestyle medicine for cancer survivorship.

Current opinion in oncology·2026

See all related articles

Treating central nervous system (CNS) leukemia remains challenging. This review covers recent advances in CNS leukemia definition, therapy, and long-term effects, discussing new agents and strategies.

Area of Science:

Oncology
Neurology
Pharmacology

Background:

Central nervous system (CNS) leukemia presents ongoing clinical challenges.
Advances in targeted therapies have not fully resolved CNS leukemia treatment difficulties.

Purpose of the Study:

To review the evolving definition and current therapeutic strategies for CNS leukemia.
To discuss pharmacological aspects and long-term sequelae of CNS-directed therapies.
To highlight novel agents and treatment approaches for CNS leukemia prevention and management.

Main Methods:

Literature review focusing on publications from the past 2 years.
Analysis of therapeutic strategies for CNS leukemia prevention and treatment.
Examination of pharmacological considerations and long-term effects.

Related Experiment Videos

Main Results:

CNS leukemia definition continues to evolve.
Current therapies face significant challenges in prevention and treatment.
Long-term sequelae of CNS-directed treatments require careful management.
Emerging agents and strategies show promise for improved outcomes.

Conclusions:

Effective management of CNS leukemia requires a comprehensive approach.
Ongoing research is crucial for developing better therapeutic options.
Addressing long-term side effects is essential for patient well-being.